Figure 4From: Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses Scatter plot of 1-Nadir/Pre-observation against AUC of TP3076+TP3011. Circle: Subject without DLT Double circle: Subject with DLT Solid line: Curve with sigmoid Emax model.Back to article page